
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
JNJ | NYSE | USD | Real-time | |
JNJ | Mexico | MXN | Delayed | |
JNJ | TradeGate | EUR | Delayed | |
JNJ | Frankfurt | EUR | Delayed | |
JNJ | Xetra | EUR | Delayed | |
JNJ | Buenos Aires | ARS | Delayed | |
DJNJ2 | Buenos Aires | ARS | Delayed | |
JNJB34 | BM&FBovespa | BRL | Delayed | |
JNJ | Vienna | EUR | Delayed | |
JNJ_KZ | KASE | USD | Delayed | |
JNJ | Colombia | COP | Delayed | |
JNJ | Lima | USD | Delayed |
For the three months ended 03 April 2022, Johnson & Johnson revenues increased 5% to $23.43B. Net income decreased 17% to $5.15B. Revenues reflect Pharmaceutical segment increase of 6% to $12.87B, Medical Devices segment increase of 6% to $6.97B, Europe segment increase of 11% to $6.02B, United States segment increase of 3% to $11.41B. Net income was offset by Acquisition and Integration related decrease from $600M (income) to $0K.
Period Ending: | Apr 03, 2022 | Jan 02, 2022 | Oct 03, 2021 | Jul 04, 2021 |
---|---|---|---|---|
Total Revenue | 23426 | 24804 | 23338 | 23312 |
Gross Profit | 15828 | 16849 | 16088 | 15725 |
Operating Income | 5862 | 4836 | 3849 | 6662 |
Net Income | 5149 | 4736 | 3667 | 6278 |
Period Ending: | Apr 03, 2022 | Jan 02, 2022 | Oct 03, 2021 | Jul 04, 2021 |
---|---|---|---|---|
Total Assets | 178355 | 182018 | 179228 | 176440 |
Total Liabilities | 103646 | 107995 | 108956 | 106860 |
Total Equity | 74709 | 74023 | 70272 | 69580 |
Period Ending: | Apr 03, 2022 | Jan 02, 2022 | Oct 03, 2021 | Jul 04, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 9 Months | 0 Months |
Cash From Operating Activities | 3979 | 23410 | 17678 | 9388 |
Cash From Investing Activities | -3634 | -8683 | -3323 | -604 |
Cash From Financing Activities | -4385 | -14047 | -10611 | -8404 |
Net Change in Cash | -4024 | 502 | 3619 | 347 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review